Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2025

Bioprosthetic Valve Fracture: Benefits and Risks

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Key Takeaways

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Clinical Insights from Navitor

Presenter: Santiago Garcia

October 27, 2025

Presentation TCT 2025

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

Presenter: Santiago Garcia

October 26, 2025

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

Todd Neale

October 25, 2025

Presentation TCT 2025

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

Presenter: Santiago Garcia

October 25, 2025

Presentation TCT 2024

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Presenter: Santiago Garcia

October 30, 2024

Presentation TCT 2024

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Presenter: Santiago Garcia

October 28, 2024

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Presentation TCT 2022

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Presenter: Santiago Garcia

September 18, 2022

Presentation TCT 2021

HALT: Long-Term Clinical Impact of Hypoattenuating Leaflet Thickening After TAVR

Presenter: Santiago Garcia

November 04, 2021

Presentation TCT 2018

Justifying the Cost for a New Cath Lab and Additional Resources for the NEW TAVR Program

Presenter: Santiago Garcia

September 24, 2018

Video

» Interview

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

September 18, 2022

Advertisement

Bioprosthetic Valve Fracture: Benefits and Risks

Transcatheter Treatment of Chronic Aortic Regurgitation Using the Novel J-Valve System: 6-Months Results from a Transfemoral Early Feasibility Study (Edwards Lifesciences)

Key Takeaways

Clinical Insights from Navitor

Heterotopic TTVR in Patients with Severe Tricuspid Regurgitation: Initial Results of the Trillium EFS (Innoventric)

TTVR Remains Safe, Effective in Presence of CIED Leads

Outcomes of Transcatheter Tricuspid Valve Replacement in Patients with and without Cardiac Implantable Electronic Devices

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Experience With J-Valve – Technology, Case Examples, and Clinical Trials

Valve Fracture for ViV TAVI Linked With Higher Mortality

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

HALT: Long-Term Clinical Impact of Hypoattenuating Leaflet Thickening After TAVR

Justifying the Cost for a New Cath Lab and Additional Resources for the NEW TAVR Program

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content